Neogen Statistics
NASDAQ: NEOGHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
10.55-0.30 (-2.76%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Neogen by the numbers
Neogen has a market capitalization of $2.30 billion based on 218.31M shares outstanding. With trailing EPS of $-0.26, Neogen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.1% below its 50-day average and 0.2% above its 200-day average.
Average daily trading volume is 3.53M shares, or about $37.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NEOG valuation vs. peer median
| Metric | NEOG | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.30B | $547.30M | +321% |
| Avg. volume | 3.53M | 1.36M | +159% |
Peer median across 8 companies: CLDX, NTLA, QUIT, QDEL, MYGN, TKNO, NNNN, ICCC.
Valuation
- Market cap
- $2.30B
- Forward P/E
- 23.44
- Price / sales (latest FY)
- 2.65
- EPS (TTM)
- $-0.26
- Shares outstanding
- 218.31M
Price and trading
- Previous close
- 10.85
- Open
- 10.76
- Day range
- 10.42 – 10.94
- 52-week range
- 5.60 – 14.26
- 52-week change
- +84.44%
- Beta
- —
- Volume
- 3.04M
- Average volume
- 3.53M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 6, 2026
Additional statistics
- Market Cap
- 2.30B
- Forward Pe
- 23.44
- Eps
- -0.26
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.26
- Week52 Low
- 5.60
- Avg Volume
- 3.53M
- Shares Outstanding
- 218.31M
- Ma50
- 12.14
- Ma200
- 10.53
- Earnings Date
- Oct 6, 2026
- Pct From52w High
- -26.02%
- Pct From52w Low
- 88.39%